Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach

US9364280B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9364280-B2
Application numberUS-201414574262-A
CountryUS
Kind codeB2
Filing dateDec 17, 2014
Priority dateApr 8, 2002
Publication dateJun 14, 2016
Grant dateJun 14, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods and apparatus are provided for pulsed electric field neuromodulation via an intra-to-extravascular approach, e.g., to effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, changes in cytokine upregulation and other conditions in target neural fibers. In some embodiments, the ITEV PEF system comprises an intravascular catheter having one or more electrodes configured for intra-to-extravascular placement across a wall of patient's vessel into proximity with target neural fibers. With the electrode(s) passing from an intravascular position to an extravascular position prior to delivery of the PEF, a magnitude of applied voltage or energy delivered via the electrode(s) and necessary to achieve desired neuromodulation may be reduced relative to an intravascular PEF system having one or more electrodes positioned solely intravascularly. The methods and apparatus of the present invention may, for example, be used to modulate one or more target neural fibers that contribute to renal function.

First claim

Opening claim text (preview).

We claim: 1. An apparatus for electric field neuromodulation, comprising: an electric field generator; an elongated element configured to be moved within a vascular structure of a patient; at least one electrode electrically coupled to the field generator and having an intravascular portion associated with the elongated element and having an extravascular portion configured to be passed through a wall of the vascular structure; and an actuator associated with the at least one electrode and being configured to move the electrode between a first position in which the extravascular portion of the electrode is within the vascular structure and a second position in which the extravascular portion of the electrode is located at an extravascular location for extravascular delivery of an electric field. 2. The apparatus of claim 1 , wherein the at least one electrode comprises at least one bipolar electrode pair having a first electrode and a second electrode, the bipolar electrode pair coupled to the field generator. 3. The apparatus of claim 2 , wherein the extravascular portion of the at least one electrode comprises the bipolar electrode pair. 4. The apparatus of claim 2 , wherein the intravascular portion of the at least one electrode comprises the first electrode of the bipolar electrode pair and the extravascular portion of the electrode comprises the second electrode of the bipolar electrode pair. 5. The apparatus of claim 2 , wherein the first electrode and the second electrode are longitudinally spaced apart from one another in the second position. 6. The apparatus of claim 1 , further comprising an external ground pad, wherein the extravascular portion of the at least one electrode is configured for monopolar extravascular delivery of the electric field. 7. The apparatus of claim 1 , wherein the actuator comprises a piercing element configured to pierce a wall of the vascular structure during movement of the extravascular portion of the at least one electrode between the first position and the second position. 8. The apparatus of claim 1 , wherein the extravascular portion of the at least one electrode comprises a piercing element configured to pierce a wall of the vascular structure during movement of the extravascular portion of the at least one electrode between the first position and the second position. 9. The apparatus of claim 1 further comprising infusate, wherein the apparatus is configured for extravascular infusion of the infusate. 10. The apparatus of claim 9 , wherein the infusate comprises neuromodulation-enhancing infusate or protective infusate. 11. The apparatus of claim 1 , wherein the actuator comprises an inflatable balloon. 12. The apparatus of claim 1 , wherein the actuator comprises an expandable cage or basket. 13. The apparatus of claim 1 , wherein the actuator comprises a transition element having a profile configured to direct the extravascular portion of the at least one electrode radially outward as the extravascular portion of the at least one electrode is moved between the first position and the second position.

Assignees

Inventors

Classifications

  • A61N1/321Primary

    Electromedical belts · CPC title

  • for enhancing the absorption properties of tissue, e.g. by electroporation · CPC title

  • for implantation or insertion into the body, e.g. heart electrode (A61N1/06 takes precedence) · CPC title

  • Neural system · CPC title

  • Electrodes for the urinary tract · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9364280B2 cover?
Methods and apparatus are provided for pulsed electric field neuromodulation via an intra-to-extravascular approach, e.g., to effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, changes in cytokine upregulation and other conditions in target neural fibers. In some embodiments, the ITEV PEF system comprises an intravas…
Who is the assignee on this patent?
Zarins Denise, Clark Benjamin J, Zadno Nicolas, and 3 more
What technology area does this patent fall under?
Primary CPC classification A61N1/321. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).